SANA Exercise Disclosure
Patel Dhavalkumar Dhirajlal · SEC Form 4 · Filed Aug 27, 2026
Exercise
Calculated transaction value
$0
Patel Dhavalkumar Dhirajlal EVP, Chief Scientific Officer
SANA
Sana Biotechnology
SANA
Transaction date
Aug 26, 2026
Public filing date
Aug 27, 2026
Filing lag
Filed 1 day later
SANA daily price context
Close on/before transaction
$4.16
Aug 26, 2026
Close before public filing
$4.16
Aug 26, 2026
Return since public filing
-24.64%
Through Sep 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 125,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002115339-26-000004
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$169.16K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Sana Biotechnology, Inc. SANA | Disposition | Aug 27, 2026 | $169.16K |
| Sana Biotechnology, Inc. SANA Current | Exercise | Aug 26, 2026 | $0 |
| Sana Biotechnology, Inc. SANA | Exercise | Aug 26, 2026 | $0 |